Related by context. Frequent words. (Click for all words.) 73 Pharmacokinetic 71 Phase 2a trial 71 Phase 2a clinical 70 Phase 1b 70 Phase IIa clinical 70 Phase 1a 70 pharmacodynamic 69 Phase 2b study 69 Phase Ib 69 phase IIb 68 pharmacokinetic 68 Phase 2a 67 phase IIa 67 Phase 1b trial 67 phase 2a 66 randomized Phase III 66 Phase 2b trial 66 orally bioavailable 66 dose escalation trial 66 Phase IIa trial 65 pharmacokinetic profile 65 Phase 1b clinical 65 noninferiority 65 Phase 2b clinical 65 ISIS # 65 Phase IIb clinical 65 PXD# 65 HGS ETR1 65 tolerability 65 dose escalation study 64 Phase IIa 64 pharmacodynamics 64 RG# [001] 64 immunogenicity 64 PS# [001] 64 dose cohorts 64 rHuPH# 64 pharmacokinetics 64 CA4P 64 multiple ascending dose 63 CYT# 63 teduglutide 63 CoFactor 63 tolerated dose MTD 63 denufosol 63 tolerability profile 63 imetelstat 63 dose limiting toxicities 63 RDEA# 63 elagolix 63 Tolerability 62 pharmacokinetic properties 62 confirmatory Phase III 62 OXi# 62 Phase 2b 62 antitumor activity 62 single ascending dose 62 efficacy endpoints 62 dose escalation 62 Phase III clinical 62 bosentan 62 multicenter clinical 62 PK PD 62 AP# [003] 62 ZYBRESTAT 62 ACTEMRA 61 safety tolerability pharmacokinetics 61 DSMB 61 Phase IIb trial 61 Secondary endpoints include 61 BCX# 61 TG# [001] 61 substudy 61 Secondary endpoints 61 SPIRIT III 61 PROMACTA 61 antithrombotic 61 radiolabeled 61 randomized controlled clinical 61 multicenter randomized double 61 BAY #-# 61 IMGN# 60 Board DSMB 60 eculizumab 60 clinical endpoints 60 NGX# 60 adalimumab 60 genotypic 60 vandetanib 60 Phase IIb 60 eltrombopag 60 metastatic renal cell carcinoma 60 TELCYTA 60 GRN#L 60 multicentre 60 Multaq R 60 Phase III 60 efficacy 60 Azixa 60 decitabine 60 unblinded